Biocon Limited

₹365.10As of Sun 8 Nov 2026, 12:00 UTC
NSE:BIOCONHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 9.16%
Div yield 0.14%
ROE 0.97%
Biotechnology
Beta (5Y) 0.34
PE TTM 124.2
TSR TTM (1.76%)
Mkt cap ₹594.5B
ROIC 2.88%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹416
13.95%
(54.03%)
Hold 10|12|11|9|9
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
5.83
6.24
6.13
6.35
25.66%
26.53%
17.61%
10.47%
Revenue₹B
49.01
50.81
52.84
53.71
7.77%
12.72%
14.76%
14.66%
Peers (US$6.330B)
Cap (US$)
PE
5.487B
84.56x
6.306B
—
Capital
TTM
5Y
10Y
Leveragex
0.525
0.051
0.037
EBIT/Intx
0.413
0.514
0.524
Own earn%
121.71
(46.90)
(44.70)
Sh yield%
23.26
29.13
30.02
Owners
Insiders/Inst%
14.25
22.24
Short interest%
4.29
SBC / revenue%
0.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
21–25
$1 testx
—
Incr. ROIC%
19